Pacira Pharmaceuticals, Inc.

NASDAQ: PCRXHealthcare / Drugs - Generic / USA
43.77+0.9900+2.31%Vol 280 4001Y Perf 17.82%
Jun 18th, 2019 16:00
BID43.73 ASK43.77
Open42.89 Previous Close42.78
Pre-Market- After-Trading43.77
 - -%  - -%
Target Price
53.64 
Analyst Rating
Moderate Buy 2.07
Potencial %
22.55 
Finscreener Ranking
★★★+     52.55
Insiders Trans % 3/6/12M
-/100/-64 
Value Ranking
     40.44
Insiders Value % 3/6/12M
-/100/-91 
Growth Ranking
★★★★     57.93
Insiders Shares Cnt. % 3/6/12M
-/100/-91 
Income Ranking
 —    -
Market Cap (mil)1 808 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
55.08 
Earnings Date
1st Aug 2019

Today's Price Range

42.5444.58

52wk Range

30.0055.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
0.09%
3 Months
7.33%
6 Months
-1.00%
1 Year
17.82%
3 Years
13.39%
5 Years
-49.28%

Name / TickerPriceChg.Chg.%
PCRX43.770.99002.31
AAPL198.454.56002.35
GOOG1 103.6011.10001.02
MSFT135.162.31001.74
XOM75.740.65000.87
WFC46.100.83001.83
JNJ140.230.79000.57
FB188.47-0.5400-0.29
GE10.420.37003.68
JPM110.711.49001.36
Earnings HistoryEstimateReportedSurprise %
Q01 20190.020.04100.00
Q04 20180.070.28300.00
Q03 2018-0.090.11222.22
Q02 2018-0.130.07153.85
Q01 2018-0.15-0.18-20.00
Q04 2017-0.080.18325.00
Q03 2017-0.23-0.1152.17
Q02 2017-0.28-0.29-3.57
Earnings Per EndEstimateRevision %Trend
6/2019 QR0.1318.18Positive
9/2019 QR0.1838.46Positive
12/2019 FY0.7917.91Positive
12/2020 FY1.4635.19Positive
Next Report Date1st Aug 2019
Estimated EPS Next Report0.13
Estimates Count6
EPS Growth Next 5 Years %23.00
Volume Overview
Volume280 400
Shares Outstanding (in ths.)41 297
Trades Count1 722
Dollar Volume9 428 255
Avg. Volume601 510
Avg. Weekly Volume382 602
Avg. Monthly Volume458 300
Avg. Quarterly Volume563 660
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (42.86 %)
6 (42.86 %)
6 (42.86 %)
Moderate Buy
1 (7.14 %)
1 (7.14 %)
1 (7.14 %)
Hold
7 (50.00 %)
7 (50.00 %)
5 (35.71 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
2 (14.29 %)
RatingModerate Buy
2.07
Moderate Buy
2.07
Moderate Buy
2.36

Pacira Pharmaceuticals, Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company have launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

CEO: David M. Stack

Teplephone: +1 973 254-3560

Address: 5 Sylvan Way, Parsippany 07054, NJ, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

60%40%

Bearish Bullish

50%50%

News